MedCity News

MedCity News MedCity News: Healthcare innovation insights for professionals. We explain the latest trends in remote patient monitoring and clinical workflows.

MedCity News is a trusted source for healthcare innovation news and analysis for busy professionals and senior executives. As the healthcare industry undergoes an overall transformation with an intense focus on value-based care, MedCity News reports on how the healthcare ecosystem – payers, providers, healthtech startups, investors, medtech, diagnostics and biopharma companies — are striving towar

d that goal. We get beyond the press releases to tell you how health IT startups, artificial intelligence companies, life science companies and hospitals are reimagining care to improve outcomes and reduce costs in a variety of chronic diseases like heart failure and diabetes as well as in cancer. MedCity News produces events that bring together the healthcare ecosystem and important stakeholders to share insights on challenges and opportunities in the industry. Check out our upcoming events here: https://events.medcitynews.com/. For healthcare startups, we have created the MedCitizens community. As a member, you will be featured on MedCityNews.com and be able to reach our newsletter audience with regular updates about your company. For experienced industry professionals and senior executives eager to showcase their thought leadership or a strong opinion, we have created the MedCity Influencers program. This outside contributors’ program is published on MedCityNews.com and circulated through our daily newsletter. Our daily newsletter reaches a senior industry audience and captures the news highlights of the day. Our weekly biopharma newsletter, BioPulse, is a weekly wrap of the most notable news in the industry in the week. Our StartUPDATES newsletter is focused on sharing news and updates from our MedCitizens. Sign up for our newsletters here: https://medcitynews.com/subscribe/.

Skye Bio Obesity Drug Fails in Phase 2; Hopes Now Ride on Higher Doses and Combo Treatment
06/10/2025

Skye Bio Obesity Drug Fails in Phase 2; Hopes Now Ride on Higher Doses and Combo Treatment

While Skye Bioscience said its drug nimacimab may yet achieve better weight loss results with higher doses, the company and analysts are interested in the drug’s potential to be combined with Novo Nordisk’s Wegovy. Skye’s drug is an antibody designed to preferentially target CB1 receptors in t...

Steps or Surgery: The Case for Wearables
06/10/2025

Steps or Surgery: The Case for Wearables

Relentlessly, rates of chronic disease, depression, and medication use continue to rise — if there were ever a time to implement alternative preventive health tools in clinical practice, now is certainly it.

The Tariff Opportunity for Medtech: Building the Supply Chain of the Future
06/10/2025

The Tariff Opportunity for Medtech: Building the Supply Chain of the Future

The current tariff volatility creates a new set of challenges for medtech companies, but uncertainty is here to stay. Companies must act now, building on the trade compliance capabilities they are building to create a resilient supply chain that is ready for future disruptions.

Reaction to UHC Store: People Aren’t Saying ‘I Love My Health Insurer — Let Me See What Else I Can Buy From Them’
06/10/2025

Reaction to UHC Store: People Aren’t Saying ‘I Love My Health Insurer — Let Me See What Else I Can Buy From Them’

UnitedHealthcare launched UHC Store to sell discounted health services directly to members, but experts question whether consumers will embrace it.

FDA Pilot Program Creates New Path for Faster Regulatory Review of Generic Drugs
05/10/2025

FDA Pilot Program Creates New Path for Faster Regulatory Review of Generic Drugs

The FDA will provide faster regulatory review of generic drugs that are tested in and manufactured in the U.S. using domestically sourced active pharmaceutical ingredients. This FDA pilot program is part of a broader Trump administration strategy to reshore pharmaceutical production.

How Medtronic & UCSF Are Giving Parkinson’s Patients Greater Control Over Their Symptoms
05/10/2025

How Medtronic & UCSF Are Giving Parkinson’s Patients Greater Control Over Their Symptoms

UCSF researcher Maria Shcherbakova highlighted how adaptive deep brain stimulation is improving Parkinson’s care by automatically adjusting brain implants in real time to better control symptoms.

Public Health Cannot Survive on Soundbites
05/10/2025

Public Health Cannot Survive on Soundbites

Premature claims about Tylenol and autism put politics ahead of science and risk eroding the public trust essential to health.

Meeting Patients Where They Are: The Value of Innovation & Collaboration in Expanding Kidney Care Access
05/10/2025

Meeting Patients Where They Are: The Value of Innovation & Collaboration in Expanding Kidney Care Access

This requires leveraging technology and partnerships in new ways to break down traditional barriers, designing therapies to fit more seamlessly into patients’ lives, and creating more equitable access to life-sustaining treatments.

Over-the-Counter CGMs Are Here — But Do They Really Make Sense for Non-Diabetics?
03/10/2025

Over-the-Counter CGMs Are Here — But Do They Really Make Sense for Non-Diabetics?

Over-the-counter continuous glucose monitors have been available for people with and without diabetes for more than a year now — but the data they collect doesn’t seem to be as useful for nondiabetic users, according to new research from Mass General Brigham.

5 Notable Health Tech Funding Announcements in September
03/10/2025

5 Notable Health Tech Funding Announcements in September

Health tech companies made several major funding announcements in September. Here is a list of some of the biggest funding rounds.

The prescription journey should be seamless, safe, and patient-friendly, yet outdated tools and disconnected systems com...
03/10/2025

The prescription journey should be seamless, safe, and patient-friendly, yet outdated tools and disconnected systems complicate it unnecessarily. In this episode of MCN Pivot podcast, our guests Javier Gonzalez, PharmD, President of PBM & Commercial Strategy at Abarca Health (sponsor), and Otto Sipe, Co-Founder & CEO, Photon Health, explore the transition toward intelligent, clinically-aligned prescribing and benefit tools.

🎥 https://youtu.be/O-oUANzAdtg

[Sponsored] The prescription journey should be seamless, safe, and patient-friendly, yet outdated tools and disconnected systems complicate it unnecessarily....

Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy
03/10/2025

Rocket Pharmaceuticals Pulls FDA Filing for Rare Blood Disorder Gene Therapy

Rocket Pharmaceuticals voluntarily withdrew its FDA submission for its Fanconi anemia gene therapy. The move follows a corporate restructuring over the summer that refocused the company on its cardiovascular programs.

Address


Telephone

+18002905460

Website

Alerts

Be the first to know and let us send you an email when MedCity News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to MedCity News:

Shortcuts

  • Want your business to be the top-listed Media Company?

Share

About Us

• MedCity News is the leading web destination for the healthcare executive community covering the latest innovations in healthcare and venture capital investment.

• The company also hosts executive healthcare conferences nationwide, attended by executives from leading providers, life sciences companies, payers, startups and investors in healthcare

Read more at www.medcitynews.com